          
Project
Highlights:
|
Company Name: |
LaVoie Group |
Situational Analysis: |
|
Project Name: |
“LaVoie Group: Adapting, Changing and Renewal in a Volatile Economic Climate” |
LaVoie Group is a life science focused agency with a team of professionals with expertise in key areas across the communications functions, including public and investor relations, marketing and corporate communications, as well as patient advocacy and government relations. We help our clients build their companies; attract capital; reach corporate partners; and third party thought leaders through integrated communications programs. LaVoie Group provides senior level counsel and tactical implementation of public, investor and corporate communications programs designed to properly position, create visibility, and drive value for each client. Our clients range from private pre-clinical start ups to industry leaders with established, marketed products in the fields of biotechnology and pharmaceuticals, specialty and OTC products... |
|
Key Achievement(s): |
▪ Added 10 new clients in 2009, which led to the creation of the agency's new pharmaceutical practice, including industry-leading pharmaceutical companies such as Pfizer, Sanofi-aventis and Invida Group. ▪ Continuing to grow our “Emerging Biotech Companies” portfolio in cutting-edge fields, including vaccines and gene therapy; Genetix Pharmaceuticals' gene therapy named to Science Magazine's “Top Breakthroughs in 2009” ▪ LaVoie Group led the PR efforts for long-term client, ESBATech, to have one of the most successful M & A exits in the pharmaceutical industry in 2009; Acquisition by Alcon for up to $550M in September 2009 |
|
Supporting URL(s): |
http://www.lavoiegroup.com/case_studies.html |
|
Award(s) Garnered: |
Winner − Best Industry-Exclusive Agency |
|
Copyright 2001-2010 - League of American Communications
Professionals LLC - All Rights
Reserved |
|
